0.00Open0.00Pre Close0 Volume0 Open Interest40.00Strike Price0.00Turnover565.10%IV-53.55%PremiumJul 19, 2024Expiry Date46.12Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9772Delta0.0015Gamma1.85Leverage Ratio-0.3324Theta0.0022Rho1.81Eff Leverage0.0035Vega
AZZ Inc Stock Discussion
In reaction to earnings/guidance:
• $New Relic(NEWR.US)$ +3.8% (guidance), $American Airlines(AAL.US)$ +2% (guidance)
Other news:
• $DICE THERAPEUTICS, INC.(DICE.US)$ +66.5% (announces "positive" topline data from its Phase 1 clinical trial of DC-806 an oral small molecule antagonist of the pro-inflammatory cytokine IL-17)
• $Albireo Pharma(ALBO.US)$ +17.2% (reports positive topline data from Phase 3 Trial of Bylvay (odevix...
- $Consolidated Communications(CNSL.US)$ +14.6%: Searchlight affirms 34.6% active holding; to evaluate the possibility of a further investment in or full acquisition.
- $Voyager Therapeutics(VYGR.US)$ +12.2%: agrees to licensing option with $Novartis AG(NVS.US)$; Voyager receives $54 million upfront.
- $Aegon Ltd(AEG.US)$ +6%: provides update on Russian and Belarusian investments following invasion of Ukraine.
- $AZZ Inc(AZZ.US)$ +...
No comment yet